HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 31 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $48,274 | +67891.5% | 62,169 | +0.0% | 0.00% | -42.9% |
Q4 2022 | $71 | -99.8% | 62,168 | -0.0% | 0.01% | +133.3% |
Q3 2022 | $31,000 | -13.9% | 62,169 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $36,000 | -55.0% | 62,169 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $80,000 | +12.7% | 62,169 | +0.0% | 0.01% | +14.3% |
Q4 2021 | $71,000 | -17.4% | 62,168 | +11.1% | 0.01% | -30.0% |
Q3 2021 | $86,000 | 0.0% | 55,978 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $86,000 | +28.4% | 55,978 | +52.8% | 0.01% | +11.1% |
Q1 2021 | $67,000 | – | 36,641 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |